Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats

Citation
By. Zeng et al., Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats, NEUROSCI L, 276(2), 1999, pp. 71-74
Citations number
21
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
276
Issue
2
Year of publication
1999
Pages
71 - 74
Database
ISI
SICI code
0304-3940(199912)276:2<71:CLTISC>2.0.ZU;2-S
Abstract
The effect of a unilateral g-hydroxydopamine (6-OHDA) lesion of the left me dial forebrain bundle and 3 weeks treatment with L-DOPA of normal and 6-OHD A lesioned rats on CB1r mRNA expression was investigated by in situ hybridi zation. A 6-OHDA lesion of nigrostriatal pathway alone, confirmed by the lo ss of nigral tyrosine hydroxylase mRNA, did not alter CB1r mRNA levels in t he dopamine depleted striatum. Similarly, chronic L-DOPA treatment of norma l rats had no effect on striatal CB1r mRNA expression. In contrast, chronic L-DOPA treatment of 6-OHDA-lesioned rats significantly increased CB1r mRNA expression in the denervated striatum. These results suggest that the CB1r activity may be altered by L-DOPA's action and this may be related to the treatment of Parkinson's disease. (C) 1999 Elsevier Science Ireland Ltd. Al l rights reserved.